Business Standard

Sunday, January 19, 2025 | 03:20 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Top headlines: Tariff troubles for telcos, India's Covid jab for children

Business Standard brings you the top stories for the day

ZyCov-D
Premium

BS Web Team New Delhi
The Union govt signalled to the telecom operators to review their low tariffs. However, the industry is hesitant to take a unified call on raising tariffs. India's drug controller gave emergency-use authorisation to Zydus Cadila's Covid vaccine which is India's first for children above 12 years. Read more on these and other top headlines for the day.


Zydus Cadila's Covid vaccine for children above 12 years gets EUA in India

The world’s first DNA-plasmid vaccine, the three-dose one for Covid-19 developed by Cadila Healthcare (Zydus Cadila), has received emergency-use authorisation from the Drugs Controller General of India (DCGI) for

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in